Professor Nader Al-Dewik

About

Dr. Al-Dewik is a Director of Translational and Precision Medicine Research, Principal Investigator at Hamad Medical Corporation (HMC), and A/Professor in Human Genetics, Genomic and Precision Medicine Program, College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU) in the State of Qatar.

As a key principal investigator, Dr. Al-Dewik has successfully gained several research grants funded by different funding bodies and secured up to USD$ 9 M between 2008 - 2023 through collaboration with several international teams on translational molecular genetics and precision medicine projects. His major research interests are in addressing high-priority maternal and neonatal health such as inherited genetic disorders, congenital anomalies, cancer/leukemia, and preterm babies.

He was also awarded an innovation fund from Qatar Science and Technology Park (QSTP) to develop a molecular kit. Dr. Al-Dewik's approach is multidisciplinary and collaborative in nature.

Dr. Al-Dewik has presented original research findings at several local, regional, and international conferences and published them in peer-reviewed journals. He has published over 50 articles in peer-reviewed journals, book chapters, and abstracts. He is acting as a reviewer for many cancer and genetics journals.

Dr. Al-Dewik is also a reviewer of research grant proposals such as The Research Council (TRC) of the Sultanate of Oman and Qatar University Internal Grants.

Dr. Al-Dewik is a managing editor of Frontiers in Bioscience special issues, academic editor of PLOS ONE, and Ad Hoc reviewer for the BMJ, PLOS ONE, the Molecular Cancer, BMC, Springer Nature, Journal of Translational Medicine, BMC, Springer Nature, the Epigenetics Taylor & Francis, Journal of Pediatric Genetics, Metagene Elsevier Journal, the Journal of Cancer Therapy (JCT), Biomarkers in Cancer, Bioinformatics and Biology Insights Journal, Cancer Informatics Journal.

Academic responsibilities

Associate Professor

Qualifications

  • Postgraduate Award: Cancer Biology & Therapeutics (CBT) program (Harvard Medical School HMS - 2016)
  • PhD Biomedical Sciences – Molecular Biology and Human Genetics (Kingston University of London and St George's Medical School - 2012)
  • MSc Medical Laboratory Sciences (Faculty of Medicine, the University of Jordan - 2003)

Teaching and learning

Research

Business, knowledge transfer and international

Videos of my work

Social media

LinkedIn